Brief: Xbiotech Announces Dismissal Of Securities Class Action Suit
24/10/2018 19:49
XBiotech Inc XBIT.O :
* XBIOTECH ANNOUNCES DISMISSAL OF SECURITIES CLASS ACTION
SUIT
* XBIOTECH INC - JUDGE DUSTIN HOWELL ISSUED LETTER RULING
GRANTING
CO'S MOTION TO DISMISS SECURITIES CLASS ACTION COMPLAINT BROUGHT
AGAINST XBIOTECH
Source text for Eikon: ID:nGNX4FBZH6
Further company coverage: XBIT.O
Recent news on XBiotech
See all newsBrief: XBiotech Announces Positive Final Efficacy Results From Phase II Taskin Trial
Brief: Xbiotech Launches Phase Ii Clinical Trial Evaluating Vilamakitug For The Treatment Of Active Axial Spondyloarthritis
Brief: Xbiotech Launches Phase Ii Clinical Trial Evaluating Vilamakitug For The Treatment Of Active Axial Spondyloarthritis
Brief: XBiotech Inc - John Simard To Retire As CEO Of XBiotech - SEC Filing
Brief: Xbiotech Announces Enrollment Completion Of Phase I Clinical Trial For Hutrukin, A Novel Candidate Therapy For Stroke